1. Home
  2. STVN vs KRC Comparison

STVN vs KRC Comparison

Compare STVN & KRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • KRC
  • Stock Information
  • Founded
  • STVN 1949
  • KRC 1947
  • Country
  • STVN Italy
  • KRC United States
  • Employees
  • STVN N/A
  • KRC N/A
  • Industry
  • STVN Containers/Packaging
  • KRC Real Estate Investment Trusts
  • Sector
  • STVN Consumer Discretionary
  • KRC Real Estate
  • Exchange
  • STVN Nasdaq
  • KRC Nasdaq
  • Market Cap
  • STVN 6.3B
  • KRC 4.3B
  • IPO Year
  • STVN 2021
  • KRC 1997
  • Fundamental
  • Price
  • STVN $21.30
  • KRC $34.82
  • Analyst Decision
  • STVN Buy
  • KRC Buy
  • Analyst Count
  • STVN 5
  • KRC 11
  • Target Price
  • STVN $30.60
  • KRC $39.20
  • AVG Volume (30 Days)
  • STVN 386.4K
  • KRC 820.8K
  • Earning Date
  • STVN 10-29-2024
  • KRC 10-23-2024
  • Dividend Yield
  • STVN 0.27%
  • KRC 6.20%
  • EPS Growth
  • STVN N/A
  • KRC N/A
  • EPS
  • STVN 0.49
  • KRC 1.68
  • Revenue
  • STVN $1,165,359,477.00
  • KRC $1,111,922,000.00
  • Revenue This Year
  • STVN $2.82
  • KRC N/A
  • Revenue Next Year
  • STVN $9.77
  • KRC $0.36
  • P/E Ratio
  • STVN $43.54
  • KRC $20.73
  • Revenue Growth
  • STVN 5.53
  • KRC N/A
  • 52 Week Low
  • STVN $16.56
  • KRC $26.78
  • 52 Week High
  • STVN $35.56
  • KRC $43.37
  • Technical
  • Relative Strength Index (RSI)
  • STVN 57.54
  • KRC 49.26
  • Support Level
  • STVN $20.68
  • KRC $35.79
  • Resistance Level
  • STVN $23.20
  • KRC $36.85
  • Average True Range (ATR)
  • STVN 1.19
  • KRC 0.89
  • MACD
  • STVN 0.20
  • KRC -0.05
  • Stochastic Oscillator
  • STVN 60.74
  • KRC 36.52

About STVN Stevanato Group S.p.A.

Stevanato Group SPA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About KRC Kilroy Realty Corporation

Kilroy Realty is a premier owner and landlord of approximately 17 million square feet of office space across Los Angeles, San Diego, the San Francisco Bay Area, Austin, Texas, and greater Seattle. The company operates as a real estate investment trust.

Share on Social Networks: